Indian River Med. Ctr. — Vero Beach, Florida

Indian River Med. Ctr. is a clinical research site located in Vero Beach, Florida, United States 32960.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Indian River Med. Ctr. has participated in 1 clinical trials.

Therapeutic areas: Venous Thrombosis, Pulmonary Embolism.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Vero Beach

Browse all research sites in Florida · View every site in Vero Beach

• Indian River Hospital
• Cleveland Clinic Indian River Hospital
• GSK Investigational Site
• Research Site
• Treasure Coast Infectious Disease Consultants
• Indian River Medical Center
• Pfizer Investigational Site
• Novartis Investigative Site
• AIDS Research and Treatment Center of the Treasure Coast
• Florida Cancer Specialists
• Vero Beach Neurology
• Vero Neurology

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indian River Med. Ctr.?

Indian River Med. Ctr. has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indian River Med. Ctr. conducted?

Indian River Med. Ctr. has 1 clinical trials on record. Their work covers Venous Thrombosis, Pulmonary Embolism.

Is Indian River Med. Ctr. accredited by Crixeo Clinical Trials?

Indian River Med. Ctr. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indian River Med. Ctr.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.